Literature DB >> 11844808

An evolving role for oral fluoropyrimidine drugs.

Robert B Diasio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844808     DOI: 10.1200/JCO.2002.20.4.894

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Breast cancer (metastatic).

Authors:  Justin Stebbing; Sarah Slater; Maurice Slevin
Journal:  BMJ Clin Evid       Date:  2007-02-01

2.  Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial.

Authors:  S Stintzing; L Fischer von Weikersthal; U Vehling-Kaiser; M Stauch; H G Hass; H Dietzfelbinger; D Oruzio; S Klein; K Zellmann; T Decker; M Schulze; W Abenhardt; G Puchtler; H Kappauf; J Mittermüller; C Haberl; C Giessen; N Moosmann; V Heinemann
Journal:  Br J Cancer       Date:  2011-07-12       Impact factor: 7.640

3.  Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review.

Authors:  Karen A Cadoo; Devika Gajria; Emily Suh; Sujata Patil; Maria Theodoulou; Larry Norton; Clifford A Hudis; Tiffany A Traina
Journal:  NPJ Breast Cancer       Date:  2016-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.